Teachers Advisors’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TVTX
SCM
CCM
PA
Teachers Advisors's TVTX Position: Q1 2019 in Review
Teachers Advisors increased its Travere Therapeutics (TVTX) stake by 2% in Q1 2019, buying an estimated $174K and bringing the position to 398,695 shares worth $9.02M. The position accounts for 0.01% of the portfolio, ranked #1047.
Teachers Advisors first reported a position in TVTX in Q1 2014 and has held it in 21 quarters since. The position peaked at $11.1M in Q3 2018. 131 funds tracked by Wall St. Rank hold TVTX as of Q1 2019.
- Teachers Advisors held 398,695 shares of Travere Therapeutics worth $9.02M as of Q1 2019.
- Teachers Advisors bought 7,889 Travere Therapeutics shares in Q1 2019, an estimated $174K.
- Travere Therapeutics made up 0.01% of Teachers Advisors's portfolio in Q1 2019, its #1047 holding.
- Teachers Advisors first reported a position in Travere Therapeutics in Q1 2014 and has held it in 21 quarters since.
- Teachers Advisors's Travere Therapeutics position peaked at $11.1M in Q3 2018.
- 131 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2019.
Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.